Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım

Merve Sapmaz Atalar; Gençer Genç

doi:10.47572/muskutd.974435

Derleme

Approach to Swallowing Disorders in Parkinson's Disease

Yıl 2022, Cilt: 9 Sayı: 2, 189 - 203, 24.08.2022

Merve Sapmaz Atalar , Gençer Genç

https://doi.org/10.47572/muskutd.974435

Cited By: 3

Öz

Most of the patients with Parkinson's disease (PD) develop dysphagia during the course of their diseases. Dysphagia, which is usually overlooked by the patients, interferes with taking solid or liquid bolus, reduces their quality of life and leads to aspiration pneumonia, which is one of the leading causes of death in PD. Disease stage, weight loss, scores >26 on Unified Parkinson’s Disease Rating Scale (UPDRS) part III, sialorrhea, and dementia have been shown to be important clinical predictors. The underlying pathophysiology of dysphagia in PD is not clear, but it has been reported that disruptions in dopaminergic and non-dopaminergic mechanisms may play a role. The assessment of dysphagia in PD includes screening tools, clinical swallowing evaluation and instrumental methods that can be used to identify patients at risk for swallowing disorders. By the help of instrumental methods such as videofluoroscopic swallowing study (VFSS) and fiberoptic endoscopic evaluation of swallowing (FEES), which are considered as the gold standard, typical deterioration patterns in the swallowing phases of Parkinson's patients can be determined, dysphagia can be diagnosed earlier, aspiration events can be detected accurately, and early intervention can be provided. Management of PD-associated dysphagia includes compensatory, rehabilitative, and medical-pharmacological methods. Optimizing dopaminergic drugs may be helpfull in some cases. More research is needed on the beneficial effects of neuromuscular electrical stimulation (NMES), deep brain stimulation (DBS), and transcranial magnetic stimulation (TMS) in the treatment of PD-associated dysphagia.

The purpose of this review is to provide an overview of the epidemiology, pathophysiology, evaluation and management of PD-associated swallowing disorders and to guide future clinical research.

Anahtar Kelimeler

Dysphagia, Parkinson, Swallowing

Kaynakça

1. Kalia LV, Lang AE. Parkinson’s disease. The Lancet, 2015;386(9996), 896–912.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
3. Simons JA. Swallowing dysfunctions in Parkinson’s disease. International Review of Neurobiology. [Internet]. Nonmotor Parkinson’s: The Hidden Face. Academic Press. 2017;134:1207–38.
4. Burke RE, O'Malley K. Axon degeneration in Parkinson's disease. Experimental Neurology. 2013;246:72-83.
5. Pringsheim T, Jette N, Frolkis A, ve ark. The prevalence of Parkinson's disease: a systematic review and meta‐analysis. Mov disord. 2014;29(13):1583-90.
6. Durmus H, Gokalp MA, Hanagasi HA. Prevalence of Parkinson’s disease in Baskale, Turkey: a population based study. Neurol Sci. 2015;36 (3):411-3.
7. Barone P, Antonini A, Colosimo C, ve ark. The PRIAMO study: a multicenter assessment of nonmotor symptomes and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24(11):1641–9.
8. Cereda E, Cilia R, Klersy C, ve ark. Swallowing disturbances in Parkinson’s disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord. 2014;20(12):1382–7.
9. Umemoto G, Furuya H. Management of dysphagia in patients with Parkinson's disease and related disorders. Intern Med. 2020;59(1):7-14.
10. Müller J, Wenning GK, Verny J, ve ark. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001;58(2):259–64.
11. Coelho M, Marti MJ, Tolosa E, ve ark. Late-stage Parkinson’s disease: the barcelona and lisbon cohort. J Neurol. 2010;257(9):1524–32.
12. Fuh J, Lee RC, Wang J, ve ark. Swallowing difficulty in Parkinson’s disease. Clin Neurol Neurosurg. 1997;99(2):106–12.
13. Pflug C, Bihler M, Emich K, ve ark. Critical dysphagia is common in Parkinson disease and occurs even in early stages: a prospective cohort study. Dysphagia. 2018;33(1):41–50.
14. Kalf JG, de Swart BJM, Bloem BR, ve ark. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18(4):311–5.
15. Rosenbek JC, Troche MS. Progressive neurologic disease and dysphagia (including Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, post-polio syndrome) In: Shaker R, Belafsky PC, Postma GN, Easterling C, editors. Principles of deglutition: a multidisciplinary text for swallowing and its disorders. San Diego: Springer; 2013.pp.395–409.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
18. Suntrup S, Teismann I, Bejer J, ve ark. Evidence for adaptive cortical changes in swallowing in Parkinson’s disease. Brain. 2013;136(3):726–38.
19. Van Hooren MR, Baijens LW, Vaskuilen S, ve ark. Treatment effects for dysphagia in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2014;20(8):800–7.
20. Warnecke T, Hamacher C, Oelenberg S, ve ark. Off and on- state assessment of swallowing function in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):1033–4.
21. Troche MS, Brandimore AE, Foote KD, ve ark. Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19(9):783–8.
22. Ciucci MR, Russell AJ, Schaser AJ, ve ark. Tongue force and timing deficits in a rat model of Parkinson disease. Behav Brain Res. 2011;222(2):315–20.
23. Ciucci MR, Schaser AJ, Russell JA. Exercise-induced rescue of tongue function without striatal dopamine sparing in a rat neurotoxin model of Parkinson disease. Behav Brain Res. 2013;252:239–45.
24. Russell AJ, Ciucci MR, Hammer MJ, ve ark. Videofluorographic assessment of deglutitive behaviors in a rat model of aging and Parkinson disease. Dysphagia. 2013;28(1):95–104.
25. Kane JR, Ciucci MR, Jacobs AN, ve ark. Asssessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson’s disease. J Commun Disord. 2011;44(5):529–37.
26. Braak H, Müller CM, Rüb U, ve ark. Pathology associated with sporadic Parkinson’s disease—Where does it end? J Neural Transm Suppl. 2006;70:89–97.
27. Suttrup I, Suttrup J, Suntrup-Krueger S, ve ark. Esophageal dysfunction in different stages of Parkinson’s disease. Neurogastroenterol Motil. 2017;29(1):e12915.
28. Mu L, Sobotka S, Chen J, ve ark. Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol. 2013;72(2):119–29.
29. Visanji NP, Marras C, Hazrati LN, ve ark. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson’s disease biomarker. Mov Disord. 2014;29:444–50.
30. Fasano A, Visanji NP, Liu LWC, ve ark. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14(6):625–39.
31. Mu L, Sobotka S, Chen J, ve ark. Parkinson’s disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol. 2013;72(7):614–23.
32. Ebihara S, Saito H, Kanda A, ve ark. Impaired efficacy of cough in patients with Parkinson disease. Chest. 2003;124(3):1009–15.
33. Schröder JB, Marian T, Claus I, ve ark. Substance P saliva reduction predicts pharyngeal dysphagia in Parkinson’s disease. Front Neurol. 2019;10:386.
34. Logemann, JA. Evaluation and treatment of swallowing disorders. Austin, Texas: pro-ed; 1998.
35. Noyce A, Silveira-Moriyama L, Gilpin P, ve ark. Severe dysphagia as a presentation of Parkinson’s disease. Mov Disord. 2012;27(3):457.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
37. Sung HY, Kim JS, Lee KS, ve ark. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson’s disease. Mov Disord. 2010;25(14):2361–8.
38. Kwon M, Lee J-H. Oro-pharyngeal dysphagia in Parkinson’s disease and related movement disorders. J Mov Disord. 2019;12(3):152–60.
39. Proulx M, de Courval FP, Wiseman MA, ve ark. Salivary production in Parkinson’s disease. Mov Disord. 2005;20(2):204–7.
40. Norbrega AC, Rodriguez B, Melo A. Silent aspiration in Parkinson’s disease patients with diurnal sialorrhea, Clin Neurol Neurosurg. 2008;110(2):117–9.
41. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(1):10–5.
42. Groher, ME., Crary, MA. Dysphagia: Clinical management in adults and children, 2nd edn. Elsevier Inc, 2016.
43. Proulx, M, De Courval, FP, Wiseman, MA, ve ark. Salivary production in Parkinson's disease. Mov Disord. 2005;20(2):204-7.
44. Perez Lloret S, Pirán Arce G, Rossi M, ve ark. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease. Mov Disord. 2007;22(1):107-11.
45. Argolo N, Sampaio M, Pinho P, ve ark. Swallowing disorders in Parkinson’s disease: impact of lingual pumping. Int J Lang Commun Disord. 2015;50(5):659–64.
46. Patel B, Legacy J, Hegland, KW, ve ark. A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspiration. Expert Rev Gastroenterol Hepatol. 2020;14(6):411-24.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
48. Claus, I, Muhle, P, Suttrup J, ve ark. Predictors of pharyngeal dysphagia in patients with parkinson’s disease. J Parkinsons Dis. 2020;10(4):1727-35.
49. Lam K, Lam FK, Lau KK, ve ark. Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson’s disease. Mov Disord. 2007;22(5):640–4.
50. Han M, Ohnishi H, Nonaka M, ve ark. Relationship between dysphagia and depressive states in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(6):437–9.
51. Coelho M, Marti MJ, Tolosa E, ve ark. Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort. J Neurol. 2010;257(9):1524–32.
52. Bird M, Woodward M, Gibson E, ve ark. Asymptomatic swallowing disorders in elderly patients with Parkinson’s disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients. Age Ageing. 1994;23(3):251–4.
53. Bushmann M, Dobmeyer S, Leeker L, ve ark. Swallowing abnormalities and their responses to treatment in Parkinson’s disease. Neurology. 1989;39(10):1309–14.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
55. Pflug C, Bihler M, Emich K, ve ark. Critical dysphagia is common in Parkinson disease and occurs even in early stages: a prospective cohort study. Dysphagia. 2018;33(1):41–50.
56. Langmore SE, Schatz K, Olsen N. Fiberoptic endoscopic examination of swallowing safety: a new procedure. Dysphagia. 1988;2(4):216–9.
57. Evatt ML, Chaudhuri KR, Chou KL, ve ark. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson’s disease. Mov Disord. 2009;24:635–46.
58. Manor Y, Giladi N, Cohen A, ve ark. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson’s disease. Mov Disord. 2007;22(13):1917–21.
59. Simons JA, Fietzek UM, Waldmann A, ve ark. Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):992–8.
60. Buhmann C, Bihler M, Emich K, ve ark. Pill swallowing in Parkinson’s disease: a prospective study based on flexible endoscopic evaluation of swallowing. Park Relat Disord. 2019;62:51–6.
61. Kalf JG, Borm GF, de Swart BJ, ve ark. Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson's disease. Arch Phys Med Rehabil. 2011;92(7):1152-8.
62. Belafsky PC, Mouadeb DA, Rees CJ, ve ark. Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919-24.
63. Demir N, Arslan SS, İnal Ö, ve ark. Reliability and validity of the Turkish eating assessment tool (T-EAT-10). Dysphagia. 2016;31(5):644-9.
64. Schlickewei O, Nienstedt, JC, Frank U, ve ark. The ability of the eating assessment tool-10 to detect penetration and aspiration in Parkinson’s disease. Eur Arch Otorhinolaryngol. 2021;278(5):1661-8.
65. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-45.
66. Chaudhuri KR, Prieto‐Jurcynska C, Naidu Y, ve ark. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704-9.
67. Kalf JG, de Swart BJ, Munneke M, ve ark. Author reply to ‘‘Oropharyngeal dysphagia in Parkinson’s disease: comments on paper by Kalf ve ark.’’ by Boot and Chaudhuri. Parkinsonism Relat Disord. 2013;19(2):276.
68. Simons JA, Fietzek UM, Waldmann A, ve ark. Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):992–8.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
71. McCullough GH, Kamarunas E, Mann GC, ve ark. Effects of Mendelsohn maneuver on measures of swallowing duration post stroke. Top Stroke Rehabil. 2012;19(3):234–43.
72. DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol. 1992;49(12):1259-61.
73. Kalf H, de Swart B, Bonnier-Baars M, ve ark. Guidelines for speech-language therapy in Parkinson’s disease. Nijmegen, the Netherlands/Miami (FL), U.S.A.: ParkinsonNet/NPF, 2008.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
75. Ertekin C, Aydogdu I, Yüceyar N, ve ark. Electrodiagnostic methods for neurogenic dysphagia. Electroencephalogr Clin Neurophysiol- Electromyogr Mot Control. 1998;109(4):331–40.
76. Potulska A, Friedman A, Królicki L, ve ark. Swallowing disorders in Parkinson’s disease. Park Relat Disord. 2003;9(6):349–53.
77. Nathadwarawala KM, McGroary A, Wiles CM. Swallowing in neurological outpatients: use of a timed test. Dysphagia. 1994;9(2):120–9.
78. Umay E, Eyigor S, Karahan AY, ve ark. The GUSS test as a good indicator to evaluate dysphagia in healthy older people: a multicenter reliability and validity study. Eur Geriatr Med. 2019;10(6):879-87.
79. Frank U, Radtke J, Nienstedt JC, ve ark. Dysphagia screening in Parkinson's disease. A diagnostic accuracy cross‐sectional study investigating the applicability of the Gugging Swallowing Screen (GUSS). Neurogastroenterol Motil. 2021;33(5):e14034.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
83. Langmore SE. History of Fiberoptic Endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia: changes over the years. Dysphagia. 2017;32(1):27–38. 84. Rosenbek JC, Robbins JA, Roecker EB, ve ark. A penetration-aspiration scale. Dysphagia. 1996;11(2):93–8.
85. Kelly AM, Drinnan MJ, Leslie P. Assessing penetration and aspiration: how do videofluoroscopy and fiberoptic endoscopic evaluation of swallowing compare? Laryngoscope. 2007;117(10):1723-7.
86. Neubauer PD, Rademaker AW, Leder SB. The Yale Pharyngeal Residue Severity Rating Scale: an anatomically defined and image-based tool. Dysphagia. 2015;30(5):521–8.
87. Pearson WG, Molfenter SM, Smith ZM, ve ark. Image-based measurement of post-swallow residue: the normalized residue ratio scale. Dysphagia. 2013;28(2):167–77.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
89. Rommel N, Borgers C, Van Beckevoort D, ve ark. Bolus Residue Scale: an easy-to-use and reliable videofluoroscopic analysis tool to score bolus residue in patients with dysphagia. Int J Otolaryngol. 2015;2015:1–7.
90. Martin-Harris B, Brodsky MB, Michel Y, ve ark. MBS measurement tool for swallow impairment-MBSimp: establishing a standard. Dysphagia. 2008;23(4):392–405.
91. Suttrup I, Suntrup S, Siemer ML, ve ark. Esophageal swallowing disorders in patients with different parkinsonian syndromes as detected by high resolution manometry. Dysphagia. 2014;29(1):121–81.
92. Troche MS, Okun MS, Rosenbek JC, ve ark. Attentional resource allocation and swallowing safety in Parkinson’s disease: a dual task study. Park Relat Disord. 2014;20(4):439–43.
93. Ertekin C. Electrophysiological evaluation of oropharyngeal dysphagia in Parkinson’s disease. J Mov Disord. 2014 ;7(2):31–56.
94. Oh DH, Park JS, Kim WJ. Effect of neuromuscular electrical stimula- tion on lip strength and closure function in patients with dysphagia after stroke. J Phys Ther Sci. 2017;29(11):1974–5.
95. Hsiao M-Y, Karunia Wahyuni L, Wang T-G. Ultrasonography in assessing oropharyngeal dysphagia. J Med Ultrasound. 2013;21(4):181–8.
96. Pitts LL, Morales S, Stierwalt JAG. Lingual pressure as a clinical indicator of swallowing function in Parkinson’s disease. J Speech Lang Hear Res. 2018;61(2):257–65.
97. Fukuoka T, Ono T, Hori K, ve ark. Tongue pressure measurement and videofluoroscopic study of swallowing in Patients with Parkinson’s disease. Dysphagia. 2019;34(1):80–8.
98. Umay E, Ozturk E, Gurcay E, ve ark. Swallowing in Parkinson’s disease: how is it affected? Clin Neurol Neurosurg. 2019;177:37–41.
99. Ertekin C, Tarlaci S, Aydogdu I, ve ark. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson’s disease. Mov Disord. 2002;17(5):942-9.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
101. Tjaden K. Speech and swallowing in Parkinson’s disease. Top Geriatric Rehabil. 2008;24(2):115–26.
102. Ra JY, Hyun JK, Ko KR, ve ark. Chin tuck for prevention of aspiration: effectiveness and appropriate posture. Dysphagia. 2014;29(5):603–9.
103. Yorkston KM, Miller RM, Strand EA. Management of speech and swallowing in degenerative diseases, Tucson, AZ, Communication Skill Builders, 1995.
104. Bisch EM, Logemann JA, Rademaker AW, ve ark. Pharyngeal effects of bolus volume, viscosity, and temperature in patients with dysphagia resulting from neurologic impairment and in normal subjects. J Speech Hear Res. 1994;37(5):1041–9.
105. Cola PC, Gatto AR, Da Silva RG, ve ark. The influence of sour taste and cold temperature in pharyngeal transit duration in patients with stroke. Arq Gastroenterol. 2010;47(1):18–21.
106. Gatto AR, Cola PC, Da Silva RG, ve ark. Sour taste and cold temperature in the oral phase of swallowing in patients after stroke. CODAS. 2013;25(2):163–7.
107. Logemann JA, Gensler G, Robbins JA, ve ark. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson’s disease. J Speech Lang Hear Res. 2008;51(1):173–83.
108. Troche MS, Sapienza CM, Rosenbek JC. Effects of bolus consistency on timing and safety of swallow in patients with Parkinson’s disease. Dysphagia. 2008;23:26–32.
109. Gillman A, Winkler R, Taylor NF. Implementing the Free Water Protocol does not result in aspiration pneumonia in carefully selected patients with dysphagia: a systematic review. Dysphagia. 2017;32(3):345–61.
110. Panther K. The Frazier Free Water Protocol. Perspect swallowing swallowing disorders. Dysphagia. 2005;14(1):4.
111. Troche MS, Okun MS, Rosenbek JC, ve ark. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology. 2010;75(21):1912–9.
112. Saleem AF, Sapienza CM, Okun MS. Respiratory muscle strength training: treatment and response duration in a patient with early idiopathic Parkinson’s disease. NeuroRehabilitation. 2005;20(4):323–33.
113. Wheeler-Hegland KM, Rosenbek JC, Sapienza CM. Submental sEMG and hyoid movement during Mendelsohn maneuver, effortful swallow, and expiratory muscle strength training. J Speech Lang Hear Res. 2008;51(5):1072–87.
114. Pitts T, Bolser D, Rosenbek J, ve ark. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest. 2009;135(5):1301–8.
115. Baker S, Davenport P, Sapienza C. Examination of strength training and detraining effects in expiratory muscles, J Speech Lang Hear Res. 2005; Dec;48(6):1325-33.
116. Troche MS, Rosenbek JC, Okun MS, Sapienza CM. Detraining outcomes with expiratory muscle strength training in Parkinson’s disease. J Rehabil Res Dev. 2014;51(2):305–10.
117. Byeon H. Effect of simultaneous application of postural techniques and expiratory muscle strength training on the enhancement of the swallowing function of patients with dysphagia caused by Parkinson’s disease. J Phys Ther Sci. 2016;28(6):1840-3.
118. Troche MS, Mishra A. Swallowing Exercises in Patients With Neurodegenerative Disease: What Is the Current Evidence?. Perspectives of the ASHA Special Interest Groups, 2017;2(13):13-20.
119. El Sharkawi A, Ramig L, Logemann JA, ve ark. Swallowing and voice effects of Lee Silverman voice treatment (LSVT®): a pilot study. J Neurol Neurosurg Psychiatry. 2002;72(1):31–6.
120. Miles A, Jardine M, Johnston F, ve ark. Effect of Lee Silverman voice treatment (LSVT LOUD®) on swallowing and cough in Parkinson’s disease: a pilot study. J Neurol Sci. 2017;383:180–7.
121. Fernandez, H. H., Walter, B. L., Rush, T., & Ahmed, A. (Eds.). A practical approach to movement disorders: diagnosis and management. Third Edition. Springer Publishing Company 2021.
122. Park JS, Hwang NK, Kim HH, ve ark. Effect of neuromuscular electrical stimulation combined with effortful swallowing using electromyographic biofeedback on oropharyngeal swallowing function in stroke patients with dysphagia: a pilot study. Medicine. 2019;98(44):e17702.
123. Crary MA, Carnaby GD, Groher ME, ve ark. Functional benefits of dysphagia therapy using adjunctive sEMG biofeedback. Dysphagia. 2004;19(3).
124. Logemann JA, Pauloski BR, Rademaker AW, ve ark. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology. 1997;11(5):651–9.
125. Regan J, Walshe M, Tobin WO. Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson’s disease. Dysphagia. 2010;25(3):207–15.
126. Argolo N, Sampaio M, Pinho P, Melo A, Nóbrega AC. Do swallowing exercises improve swallowing dynamic and quality of life in Parkinson's disease?. NeuroRehabilitation. 2013;32(4):949-55. 127. Einarsdóttir ER, Gunnsteinsdóttir H, Hallsdóttir MH, ve ark. Dental health of patients with Parkinson’s disease in Iceland. Spec Care Dent. 2009;29(3):123-7.
128. Fukayo S, Nonaka K, Shimizu T, ve ark. Oral health of patients with Parkinson’s disease: factors related to their better dental status. Tohoku J Exp Med. 2003;201(3):171–9.
129. Friedlander AH, Mahler M, Norman KM, ve ark. Parkinson disease: Parkinson disease systemic and orofacial manifestations, medical and dental management. J Am Dent Assoc. 2009;140(6):658–69.
130. Battel I, Calvo I, Walshe M. Interventions involving Biofeedback to improve swallowing in people with Parkinson’s Disease and dysphagia: A systematic review. Arch Phys Med Rehabil. 2021;102(2):314-22.
131. Manor Y, Mootanah R, Freud D, ve ark. Video-assisted swallowing therapy for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19(2):207–11.
132. Athukorala RP, Jones RD, Sella O, ve ark. Skill training for swallowing rehabilitation in patients with Parkinson’s disease. Arch Phys Med Rehabil. 2014;95:1374.
133. Felix VN, Corréa SM, Soares RJ. A therapeutic maneuver for oropharyngeal dysphagia in patients with Parkinson’s disease. Clinics. 2008;63:661.
134. Sutton JP. Dysphagia in Parkinson’s disease is responsive to levodopa. Park Relat Disord. 2013;19(3):282–4.
135. Hunter P, Crameri J, Austin S, ve ark. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry. 1997;63(5):579–83.
136. Tison F, Wiart L, Guatterie M, ve ark. Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease. Mov Disord. 1996;11(6):729–32.
137. Melo A, Monteiro L. Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: Lack of evidence. Parkinsonism Relat Disord. 2013;19(3):279-81.
138. Lim A, Leow L, Huckabee M, ve ark. A pilot study of respiration and swallowing integration in Parkinson’s disease: ‘on’ and ‘off’ levodopa. Dysphagia. 2008;23:76–81.
139. Warnecke T, Suttrup I, Schröder JB, ve ark. Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test. Parkinsonism Relat Disord. 2016;28:100-6.
140. Nóbrega AC, Pinho P, Deiró M, ve ark. Levodopa treatment in Parkinson's disease: how does it affect dysphagia management?. Parkinsonism Relat Disord. 2014;20(3):340-1.
141. Suttrup I, Oelenberg S, Hamacher C, ve ark. Endoscopic L-dopa-test for parkinsonian dysphagia (a pilot study). Dysphagia. 2011;26:482.
142. Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med. 2002;346(15):1174-5.
143. Yorkston KM, Miller RM, Strand EA. Management of Speech and Swallowing in Degenerative Diseases. Austin, Texas: Pro-ed; 2004.
144. Roche V. Percutaneous endoscopic gastrostomy. Clinical care of PEG tubes in older adults. Geriatrics. 2003;58(11):22–6.
145. Loeb M, McGeer A, McArthur M, ve ark. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med. 1999;159(17):2058–64. 146. Opilla M. Aspiration risk and enteral feeding: a clinical approach. Pract Gastroenterol. 2003;1(27):89–96.
147. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003;124(1):328–36.
148. Ciocon JO, Silverstone FA, Graver LM, ve ark. Tube feedings in elderly patients: indications, benefits, and complications. Arch Intern Med. 1988;148(2):429–33.
149. Baijens LWJ, Speyer R, Passos VL, ve ark. The effect of surface electrical stimulation on swallowing in dysphagic parkinson patients. Dysphagia. 2012;27(4):528–37.
150. Heijnen BJ, Speyer R, Baijens LW, ve ark. Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson’s disease and oropharyngeal dysphagia: effects on quality of life. Dysphagia. 2012;27(3):336-45.
151. Lengerer S, Kipping J, Rommel N, ve ark. Deep brain stimulation does not impair deglutition in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:847–53.
152. Sunstedt S, Olofsson K, van Doorn J, ve ark. Swallowing function in Parkinson’s patients following zona incerta deep brain stimulation. Acta Neurol Scand. 2012;12:350–6.
153. Kulneff L, Sundstedt S, Olofsson K, ve ark. Deep brain stimulation-effects on swallowing function in Parkinson’s disease. Acta Neurol Scand. 2012;1:1–8.
154. Silbergleit AK, Lewitt P, Junn F, ve ark. Comparison of dysphagia before and after deep brain stimulation in Parkinson’s disease. Mov Disord. 2012;27:1763–8.
155. Kitashima A, Umemoto G, Tsuboi Y, ve ark. Effects of subthalamic nucleus deep brain stimulation on the swallowing function of patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:480-2.
156. Ciucci MR, Brakmeier-Kraemer JM, Shermann SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease. Mov Disord. 2008;23(5):676–83.
157. Xie T, Vigil J, MacCracken E, ve ark. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 2015;84(4):415–20.
158. Xie T, Bloom L, Padmanaban M, ve ark. Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. J Neurol Neurosurg Psychiatry. 2018;89:989–94.
159. Derrey S, Chastan N, Maltete D, ve ark. Impact of deep brain stimulation on pharyngo-esophageal motility: a randomized cross-over study. Neurogastroenterol Motil. 2015;27:1214–22.
160. Shin J, Yang E, Cho K, ve ark. Clinical application of repetitive transcranial magnetic stimulation in stroke rehabilitation. Neural Regen Res. 2012;7(8):627–34.
161. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg. 2008;16(3):205–10.
162. Khedr EM, Mohamed KO, Soliman RK, ve ark. The effect of high-frequency repetitive transcranial magnetic stimulation on advancing Parkinson’s disease with dysphagia: double blind randomized clinical trial. Neurorehabil Neural Repair. 2019;33(6):442-52.

Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım

Yıl 2022, Cilt: 9 Sayı: 2, 189 - 203, 24.08.2022

Merve Sapmaz Atalar , Gençer Genç

https://doi.org/10.47572/muskutd.974435

Cited By: 3

Öz

Parkinson hastalığı (PH) olan kişilerin büyük bir kısmında, hastalıklarının seyri sırasında yutma bozukluğu (disfaji) gelişir. Hastalar tarafından genellikle arka planda tutulan disfaji, katı veya sıvı bolus alımını zorlaştırır, yaşam kalitesini azaltır ve PH'de başta gelen ölüm nedenlerinden biri olan aspirasyon pnömonisine yol açar. Yutma bozukluğu gelişiminde hastalık evresi, kilo kaybı, Birleşik Parkinson Hastalığı Derecelendirme Ölçeği (BPHDÖ) bölüm III skorunun >26 olması, demans ve siyalore gibi klinik öngörücüler bulunmaktadır. PH’de disfajinin altta yatan patofizyolojisi tam olarak anlaşılamamasına rağmen dopaminerjik ve dopaminerjik olmayan mekanizmalardaki bozulmaların rol oynayabileceği bildirilmiştir. PH'de ortaya çıkan disfajinin değerlendirmesinde tarama araçları, klinik yutma değerlendirmesi ve enstrümantal yöntemler, yutma bozukluğu riski taşıyan hastaları belirlemek için kullanılabilir. Altın standart olarak düşünülen videofloroskopik yutma çalışması (VFYÇ) ve fiberoptik endoskopik yutma değerlendirmesi (FEYD) gibi enstrümantal yöntemler ile Parkinson hastalarının yutma fazlarındaki tipik bozulma paternleri belirlenebilir, disfaji daha erken tanılanabilir, aspirasyon olayları doğru bir şekilde tespit edilebilir ve erken müdahale sağlanabilir. PH ile ilişkili disfajinin yönetimi, kompansatuar, rehabilitatif ve tıbbi-farmakolojik yöntemleri içerir. Dopaminerjik ilaçların optimize edilmesi bazı durumlarda faydalı olabilir. Nöromusküler elektriksel stimülasyon (NMES), derin beyin stimülasyonu (DBS) ve transkraniyal manyetik stimülasyonun (TMS) PH ile ilişkili disfajinin tedavisinde faydalı etkilerine yönelik daha fazla araştırmaya ihtiyaç vardır. Bu derlemenin amacı, PH ile ilişkili yutma bozukluklarının epidemiyolojisi, patofizyolojisi, değerlendirilmesi ve yönetimi hakkında genel bir bakış açısı sunmak ve gelecekteki klinik araştırmalar için yol gösterici olmaktır.

Anahtar Kelimeler

Disfaji, Parkinson, Yutma

Kaynakça

1. Kalia LV, Lang AE. Parkinson’s disease. The Lancet, 2015;386(9996), 896–912.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
2. Suttrup I, Warnecke T. Dysphagia in Parkinson’s disease. Dysphagia. 2016;31(1):24–32.
3. Simons JA. Swallowing dysfunctions in Parkinson’s disease. International Review of Neurobiology. [Internet]. Nonmotor Parkinson’s: The Hidden Face. Academic Press. 2017;134:1207–38.
4. Burke RE, O'Malley K. Axon degeneration in Parkinson's disease. Experimental Neurology. 2013;246:72-83.
5. Pringsheim T, Jette N, Frolkis A, ve ark. The prevalence of Parkinson's disease: a systematic review and meta‐analysis. Mov disord. 2014;29(13):1583-90.
6. Durmus H, Gokalp MA, Hanagasi HA. Prevalence of Parkinson’s disease in Baskale, Turkey: a population based study. Neurol Sci. 2015;36 (3):411-3.
7. Barone P, Antonini A, Colosimo C, ve ark. The PRIAMO study: a multicenter assessment of nonmotor symptomes and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24(11):1641–9.
8. Cereda E, Cilia R, Klersy C, ve ark. Swallowing disturbances in Parkinson’s disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord. 2014;20(12):1382–7.
9. Umemoto G, Furuya H. Management of dysphagia in patients with Parkinson's disease and related disorders. Intern Med. 2020;59(1):7-14.
10. Müller J, Wenning GK, Verny J, ve ark. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001;58(2):259–64.
11. Coelho M, Marti MJ, Tolosa E, ve ark. Late-stage Parkinson’s disease: the barcelona and lisbon cohort. J Neurol. 2010;257(9):1524–32.
12. Fuh J, Lee RC, Wang J, ve ark. Swallowing difficulty in Parkinson’s disease. Clin Neurol Neurosurg. 1997;99(2):106–12.
13. Pflug C, Bihler M, Emich K, ve ark. Critical dysphagia is common in Parkinson disease and occurs even in early stages: a prospective cohort study. Dysphagia. 2018;33(1):41–50.
14. Kalf JG, de Swart BJM, Bloem BR, ve ark. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18(4):311–5.
15. Rosenbek JC, Troche MS. Progressive neurologic disease and dysphagia (including Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, post-polio syndrome) In: Shaker R, Belafsky PC, Postma GN, Easterling C, editors. Principles of deglutition: a multidisciplinary text for swallowing and its disorders. San Diego: Springer; 2013.pp.395–409.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
16. Michou E, Hamdy S. Dysphagia in Parkinson’s disease: a therapeutic challenge? Expert Rev Neurother. 2010;10(6):875–8.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
17. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia. 2010;25(3):250–7.
18. Suntrup S, Teismann I, Bejer J, ve ark. Evidence for adaptive cortical changes in swallowing in Parkinson’s disease. Brain. 2013;136(3):726–38.
19. Van Hooren MR, Baijens LW, Vaskuilen S, ve ark. Treatment effects for dysphagia in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2014;20(8):800–7.
20. Warnecke T, Hamacher C, Oelenberg S, ve ark. Off and on- state assessment of swallowing function in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):1033–4.
21. Troche MS, Brandimore AE, Foote KD, ve ark. Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19(9):783–8.
22. Ciucci MR, Russell AJ, Schaser AJ, ve ark. Tongue force and timing deficits in a rat model of Parkinson disease. Behav Brain Res. 2011;222(2):315–20.
23. Ciucci MR, Schaser AJ, Russell JA. Exercise-induced rescue of tongue function without striatal dopamine sparing in a rat neurotoxin model of Parkinson disease. Behav Brain Res. 2013;252:239–45.
24. Russell AJ, Ciucci MR, Hammer MJ, ve ark. Videofluorographic assessment of deglutitive behaviors in a rat model of aging and Parkinson disease. Dysphagia. 2013;28(1):95–104.
25. Kane JR, Ciucci MR, Jacobs AN, ve ark. Asssessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson’s disease. J Commun Disord. 2011;44(5):529–37.
26. Braak H, Müller CM, Rüb U, ve ark. Pathology associated with sporadic Parkinson’s disease—Where does it end? J Neural Transm Suppl. 2006;70:89–97.
27. Suttrup I, Suttrup J, Suntrup-Krueger S, ve ark. Esophageal dysfunction in different stages of Parkinson’s disease. Neurogastroenterol Motil. 2017;29(1):e12915.
28. Mu L, Sobotka S, Chen J, ve ark. Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol. 2013;72(2):119–29.
29. Visanji NP, Marras C, Hazrati LN, ve ark. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson’s disease biomarker. Mov Disord. 2014;29:444–50.
30. Fasano A, Visanji NP, Liu LWC, ve ark. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14(6):625–39.
31. Mu L, Sobotka S, Chen J, ve ark. Parkinson’s disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol. 2013;72(7):614–23.
32. Ebihara S, Saito H, Kanda A, ve ark. Impaired efficacy of cough in patients with Parkinson disease. Chest. 2003;124(3):1009–15.
33. Schröder JB, Marian T, Claus I, ve ark. Substance P saliva reduction predicts pharyngeal dysphagia in Parkinson’s disease. Front Neurol. 2019;10:386.
34. Logemann, JA. Evaluation and treatment of swallowing disorders. Austin, Texas: pro-ed; 1998.
35. Noyce A, Silveira-Moriyama L, Gilpin P, ve ark. Severe dysphagia as a presentation of Parkinson’s disease. Mov Disord. 2012;27(3):457.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
36. Murry T, Carrau RL, Chan K. Clinical management of swallowing disorders, 4th ed. Plural Publishing, 2018.
37. Sung HY, Kim JS, Lee KS, ve ark. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson’s disease. Mov Disord. 2010;25(14):2361–8.
38. Kwon M, Lee J-H. Oro-pharyngeal dysphagia in Parkinson’s disease and related movement disorders. J Mov Disord. 2019;12(3):152–60.
39. Proulx M, de Courval FP, Wiseman MA, ve ark. Salivary production in Parkinson’s disease. Mov Disord. 2005;20(2):204–7.
40. Norbrega AC, Rodriguez B, Melo A. Silent aspiration in Parkinson’s disease patients with diurnal sialorrhea, Clin Neurol Neurosurg. 2008;110(2):117–9.
41. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(1):10–5.
42. Groher, ME., Crary, MA. Dysphagia: Clinical management in adults and children, 2nd edn. Elsevier Inc, 2016.
43. Proulx, M, De Courval, FP, Wiseman, MA, ve ark. Salivary production in Parkinson's disease. Mov Disord. 2005;20(2):204-7.
44. Perez Lloret S, Pirán Arce G, Rossi M, ve ark. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease. Mov Disord. 2007;22(1):107-11.
45. Argolo N, Sampaio M, Pinho P, ve ark. Swallowing disorders in Parkinson’s disease: impact of lingual pumping. Int J Lang Commun Disord. 2015;50(5):659–64.
46. Patel B, Legacy J, Hegland, KW, ve ark. A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspiration. Expert Rev Gastroenterol Hepatol. 2020;14(6):411-24.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
47. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in Parkinson’s disease. J Parkinsons Dis. 2013;3(1):39–44.
48. Claus, I, Muhle, P, Suttrup J, ve ark. Predictors of pharyngeal dysphagia in patients with parkinson’s disease. J Parkinsons Dis. 2020;10(4):1727-35.
49. Lam K, Lam FK, Lau KK, ve ark. Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson’s disease. Mov Disord. 2007;22(5):640–4.
50. Han M, Ohnishi H, Nonaka M, ve ark. Relationship between dysphagia and depressive states in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(6):437–9.
51. Coelho M, Marti MJ, Tolosa E, ve ark. Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort. J Neurol. 2010;257(9):1524–32.
52. Bird M, Woodward M, Gibson E, ve ark. Asymptomatic swallowing disorders in elderly patients with Parkinson’s disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients. Age Ageing. 1994;23(3):251–4.
53. Bushmann M, Dobmeyer S, Leeker L, ve ark. Swallowing abnormalities and their responses to treatment in Parkinson’s disease. Neurology. 1989;39(10):1309–14.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
54. Prosiegel M. Neurogene dysphagien. In: Diener H, Weimar C, editors. Leitlinien für Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2008.
55. Pflug C, Bihler M, Emich K, ve ark. Critical dysphagia is common in Parkinson disease and occurs even in early stages: a prospective cohort study. Dysphagia. 2018;33(1):41–50.
56. Langmore SE, Schatz K, Olsen N. Fiberoptic endoscopic examination of swallowing safety: a new procedure. Dysphagia. 1988;2(4):216–9.
57. Evatt ML, Chaudhuri KR, Chou KL, ve ark. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson’s disease. Mov Disord. 2009;24:635–46.
58. Manor Y, Giladi N, Cohen A, ve ark. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson’s disease. Mov Disord. 2007;22(13):1917–21.
59. Simons JA, Fietzek UM, Waldmann A, ve ark. Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):992–8.
60. Buhmann C, Bihler M, Emich K, ve ark. Pill swallowing in Parkinson’s disease: a prospective study based on flexible endoscopic evaluation of swallowing. Park Relat Disord. 2019;62:51–6.
61. Kalf JG, Borm GF, de Swart BJ, ve ark. Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson's disease. Arch Phys Med Rehabil. 2011;92(7):1152-8.
62. Belafsky PC, Mouadeb DA, Rees CJ, ve ark. Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919-24.
63. Demir N, Arslan SS, İnal Ö, ve ark. Reliability and validity of the Turkish eating assessment tool (T-EAT-10). Dysphagia. 2016;31(5):644-9.
64. Schlickewei O, Nienstedt, JC, Frank U, ve ark. The ability of the eating assessment tool-10 to detect penetration and aspiration in Parkinson’s disease. Eur Arch Otorhinolaryngol. 2021;278(5):1661-8.
65. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-45.
66. Chaudhuri KR, Prieto‐Jurcynska C, Naidu Y, ve ark. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704-9.
67. Kalf JG, de Swart BJ, Munneke M, ve ark. Author reply to ‘‘Oropharyngeal dysphagia in Parkinson’s disease: comments on paper by Kalf ve ark.’’ by Boot and Chaudhuri. Parkinsonism Relat Disord. 2013;19(2):276.
68. Simons JA, Fietzek UM, Waldmann A, ve ark. Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(9):992–8.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
69. Fahn S, Elton R. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease. Florham Park: Macmillan Healthcare Information; 1987. p. 153–63.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
70. Topbaş S. İletişim Bozukluklarına Giriş. Mirket Akademik Yayınları, İstanbul, 2021.
71. McCullough GH, Kamarunas E, Mann GC, ve ark. Effects of Mendelsohn maneuver on measures of swallowing duration post stroke. Top Stroke Rehabil. 2012;19(3):234–43.
72. DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol. 1992;49(12):1259-61.
73. Kalf H, de Swart B, Bonnier-Baars M, ve ark. Guidelines for speech-language therapy in Parkinson’s disease. Nijmegen, the Netherlands/Miami (FL), U.S.A.: ParkinsonNet/NPF, 2008.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
74. Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Neurol. 2014;17(1):62–5.
75. Ertekin C, Aydogdu I, Yüceyar N, ve ark. Electrodiagnostic methods for neurogenic dysphagia. Electroencephalogr Clin Neurophysiol- Electromyogr Mot Control. 1998;109(4):331–40.
76. Potulska A, Friedman A, Królicki L, ve ark. Swallowing disorders in Parkinson’s disease. Park Relat Disord. 2003;9(6):349–53.
77. Nathadwarawala KM, McGroary A, Wiles CM. Swallowing in neurological outpatients: use of a timed test. Dysphagia. 1994;9(2):120–9.
78. Umay E, Eyigor S, Karahan AY, ve ark. The GUSS test as a good indicator to evaluate dysphagia in healthy older people: a multicenter reliability and validity study. Eur Geriatr Med. 2019;10(6):879-87.
79. Frank U, Radtke J, Nienstedt JC, ve ark. Dysphagia screening in Parkinson's disease. A diagnostic accuracy cross‐sectional study investigating the applicability of the Gugging Swallowing Screen (GUSS). Neurogastroenterol Motil. 2021;33(5):e14034.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
80. Sarıkaya D. Geriatrik hastalarda mini nütrisyonel değerlendirme (MNA) testinin uzun ve kısa (MNA-SF) formunun geçerlilik çalışması. 2013.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
81. Carnaby-Mann G, Lenius K. The bedside examination in dysphagia. Phys Med Rehabil Clin N Am. 2008;19(4):747–68.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
82. Langmore SE. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngnol Head Neck Surg. 2003;11:485–9.
83. Langmore SE. History of Fiberoptic Endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia: changes over the years. Dysphagia. 2017;32(1):27–38. 84. Rosenbek JC, Robbins JA, Roecker EB, ve ark. A penetration-aspiration scale. Dysphagia. 1996;11(2):93–8.
85. Kelly AM, Drinnan MJ, Leslie P. Assessing penetration and aspiration: how do videofluoroscopy and fiberoptic endoscopic evaluation of swallowing compare? Laryngoscope. 2007;117(10):1723-7.
86. Neubauer PD, Rademaker AW, Leder SB. The Yale Pharyngeal Residue Severity Rating Scale: an anatomically defined and image-based tool. Dysphagia. 2015;30(5):521–8.
87. Pearson WG, Molfenter SM, Smith ZM, ve ark. Image-based measurement of post-swallow residue: the normalized residue ratio scale. Dysphagia. 2013;28(2):167–77.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
88. Dyer JC, Leslie P, Drinnan MJ. Objective computer-based assessment of valleculae residue- Is it useful? Dysphagia. 2008;23(1):7–15.
89. Rommel N, Borgers C, Van Beckevoort D, ve ark. Bolus Residue Scale: an easy-to-use and reliable videofluoroscopic analysis tool to score bolus residue in patients with dysphagia. Int J Otolaryngol. 2015;2015:1–7.
90. Martin-Harris B, Brodsky MB, Michel Y, ve ark. MBS measurement tool for swallow impairment-MBSimp: establishing a standard. Dysphagia. 2008;23(4):392–405.
91. Suttrup I, Suntrup S, Siemer ML, ve ark. Esophageal swallowing disorders in patients with different parkinsonian syndromes as detected by high resolution manometry. Dysphagia. 2014;29(1):121–81.
92. Troche MS, Okun MS, Rosenbek JC, ve ark. Attentional resource allocation and swallowing safety in Parkinson’s disease: a dual task study. Park Relat Disord. 2014;20(4):439–43.
93. Ertekin C. Electrophysiological evaluation of oropharyngeal dysphagia in Parkinson’s disease. J Mov Disord. 2014 ;7(2):31–56.
94. Oh DH, Park JS, Kim WJ. Effect of neuromuscular electrical stimula- tion on lip strength and closure function in patients with dysphagia after stroke. J Phys Ther Sci. 2017;29(11):1974–5.
95. Hsiao M-Y, Karunia Wahyuni L, Wang T-G. Ultrasonography in assessing oropharyngeal dysphagia. J Med Ultrasound. 2013;21(4):181–8.
96. Pitts LL, Morales S, Stierwalt JAG. Lingual pressure as a clinical indicator of swallowing function in Parkinson’s disease. J Speech Lang Hear Res. 2018;61(2):257–65.
97. Fukuoka T, Ono T, Hori K, ve ark. Tongue pressure measurement and videofluoroscopic study of swallowing in Patients with Parkinson’s disease. Dysphagia. 2019;34(1):80–8.
98. Umay E, Ozturk E, Gurcay E, ve ark. Swallowing in Parkinson’s disease: how is it affected? Clin Neurol Neurosurg. 2019;177:37–41.
99. Ertekin C, Tarlaci S, Aydogdu I, ve ark. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson’s disease. Mov Disord. 2002;17(5):942-9.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
100. Genc G. Nutritional Considerations. In H. Fernandez & A. Machado & M. Pandya (Eds.), A Practical Approach to Movement Disorders: Diagnosis and Management, 2nd Edition. (pp. 266-77). New York, NY: Demos Medical Publishing. (ISBN:9781620700341). 2015.
101. Tjaden K. Speech and swallowing in Parkinson’s disease. Top Geriatric Rehabil. 2008;24(2):115–26.
102. Ra JY, Hyun JK, Ko KR, ve ark. Chin tuck for prevention of aspiration: effectiveness and appropriate posture. Dysphagia. 2014;29(5):603–9.
103. Yorkston KM, Miller RM, Strand EA. Management of speech and swallowing in degenerative diseases, Tucson, AZ, Communication Skill Builders, 1995.
104. Bisch EM, Logemann JA, Rademaker AW, ve ark. Pharyngeal effects of bolus volume, viscosity, and temperature in patients with dysphagia resulting from neurologic impairment and in normal subjects. J Speech Hear Res. 1994;37(5):1041–9.
105. Cola PC, Gatto AR, Da Silva RG, ve ark. The influence of sour taste and cold temperature in pharyngeal transit duration in patients with stroke. Arq Gastroenterol. 2010;47(1):18–21.
106. Gatto AR, Cola PC, Da Silva RG, ve ark. Sour taste and cold temperature in the oral phase of swallowing in patients after stroke. CODAS. 2013;25(2):163–7.
107. Logemann JA, Gensler G, Robbins JA, ve ark. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson’s disease. J Speech Lang Hear Res. 2008;51(1):173–83.
108. Troche MS, Sapienza CM, Rosenbek JC. Effects of bolus consistency on timing and safety of swallow in patients with Parkinson’s disease. Dysphagia. 2008;23:26–32.
109. Gillman A, Winkler R, Taylor NF. Implementing the Free Water Protocol does not result in aspiration pneumonia in carefully selected patients with dysphagia: a systematic review. Dysphagia. 2017;32(3):345–61.
110. Panther K. The Frazier Free Water Protocol. Perspect swallowing swallowing disorders. Dysphagia. 2005;14(1):4.
111. Troche MS, Okun MS, Rosenbek JC, ve ark. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology. 2010;75(21):1912–9.
112. Saleem AF, Sapienza CM, Okun MS. Respiratory muscle strength training: treatment and response duration in a patient with early idiopathic Parkinson’s disease. NeuroRehabilitation. 2005;20(4):323–33.
113. Wheeler-Hegland KM, Rosenbek JC, Sapienza CM. Submental sEMG and hyoid movement during Mendelsohn maneuver, effortful swallow, and expiratory muscle strength training. J Speech Lang Hear Res. 2008;51(5):1072–87.
114. Pitts T, Bolser D, Rosenbek J, ve ark. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest. 2009;135(5):1301–8.
115. Baker S, Davenport P, Sapienza C. Examination of strength training and detraining effects in expiratory muscles, J Speech Lang Hear Res. 2005; Dec;48(6):1325-33.
116. Troche MS, Rosenbek JC, Okun MS, Sapienza CM. Detraining outcomes with expiratory muscle strength training in Parkinson’s disease. J Rehabil Res Dev. 2014;51(2):305–10.
117. Byeon H. Effect of simultaneous application of postural techniques and expiratory muscle strength training on the enhancement of the swallowing function of patients with dysphagia caused by Parkinson’s disease. J Phys Ther Sci. 2016;28(6):1840-3.
118. Troche MS, Mishra A. Swallowing Exercises in Patients With Neurodegenerative Disease: What Is the Current Evidence?. Perspectives of the ASHA Special Interest Groups, 2017;2(13):13-20.
119. El Sharkawi A, Ramig L, Logemann JA, ve ark. Swallowing and voice effects of Lee Silverman voice treatment (LSVT®): a pilot study. J Neurol Neurosurg Psychiatry. 2002;72(1):31–6.
120. Miles A, Jardine M, Johnston F, ve ark. Effect of Lee Silverman voice treatment (LSVT LOUD®) on swallowing and cough in Parkinson’s disease: a pilot study. J Neurol Sci. 2017;383:180–7.
121. Fernandez, H. H., Walter, B. L., Rush, T., & Ahmed, A. (Eds.). A practical approach to movement disorders: diagnosis and management. Third Edition. Springer Publishing Company 2021.
122. Park JS, Hwang NK, Kim HH, ve ark. Effect of neuromuscular electrical stimulation combined with effortful swallowing using electromyographic biofeedback on oropharyngeal swallowing function in stroke patients with dysphagia: a pilot study. Medicine. 2019;98(44):e17702.
123. Crary MA, Carnaby GD, Groher ME, ve ark. Functional benefits of dysphagia therapy using adjunctive sEMG biofeedback. Dysphagia. 2004;19(3).
124. Logemann JA, Pauloski BR, Rademaker AW, ve ark. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology. 1997;11(5):651–9.
125. Regan J, Walshe M, Tobin WO. Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson’s disease. Dysphagia. 2010;25(3):207–15.
126. Argolo N, Sampaio M, Pinho P, Melo A, Nóbrega AC. Do swallowing exercises improve swallowing dynamic and quality of life in Parkinson's disease?. NeuroRehabilitation. 2013;32(4):949-55. 127. Einarsdóttir ER, Gunnsteinsdóttir H, Hallsdóttir MH, ve ark. Dental health of patients with Parkinson’s disease in Iceland. Spec Care Dent. 2009;29(3):123-7.
128. Fukayo S, Nonaka K, Shimizu T, ve ark. Oral health of patients with Parkinson’s disease: factors related to their better dental status. Tohoku J Exp Med. 2003;201(3):171–9.
129. Friedlander AH, Mahler M, Norman KM, ve ark. Parkinson disease: Parkinson disease systemic and orofacial manifestations, medical and dental management. J Am Dent Assoc. 2009;140(6):658–69.
130. Battel I, Calvo I, Walshe M. Interventions involving Biofeedback to improve swallowing in people with Parkinson’s Disease and dysphagia: A systematic review. Arch Phys Med Rehabil. 2021;102(2):314-22.
131. Manor Y, Mootanah R, Freud D, ve ark. Video-assisted swallowing therapy for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19(2):207–11.
132. Athukorala RP, Jones RD, Sella O, ve ark. Skill training for swallowing rehabilitation in patients with Parkinson’s disease. Arch Phys Med Rehabil. 2014;95:1374.
133. Felix VN, Corréa SM, Soares RJ. A therapeutic maneuver for oropharyngeal dysphagia in patients with Parkinson’s disease. Clinics. 2008;63:661.
134. Sutton JP. Dysphagia in Parkinson’s disease is responsive to levodopa. Park Relat Disord. 2013;19(3):282–4.
135. Hunter P, Crameri J, Austin S, ve ark. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry. 1997;63(5):579–83.
136. Tison F, Wiart L, Guatterie M, ve ark. Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease. Mov Disord. 1996;11(6):729–32.
137. Melo A, Monteiro L. Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: Lack of evidence. Parkinsonism Relat Disord. 2013;19(3):279-81.
138. Lim A, Leow L, Huckabee M, ve ark. A pilot study of respiration and swallowing integration in Parkinson’s disease: ‘on’ and ‘off’ levodopa. Dysphagia. 2008;23:76–81.
139. Warnecke T, Suttrup I, Schröder JB, ve ark. Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test. Parkinsonism Relat Disord. 2016;28:100-6.
140. Nóbrega AC, Pinho P, Deiró M, ve ark. Levodopa treatment in Parkinson's disease: how does it affect dysphagia management?. Parkinsonism Relat Disord. 2014;20(3):340-1.
141. Suttrup I, Oelenberg S, Hamacher C, ve ark. Endoscopic L-dopa-test for parkinsonian dysphagia (a pilot study). Dysphagia. 2011;26:482.
142. Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med. 2002;346(15):1174-5.
143. Yorkston KM, Miller RM, Strand EA. Management of Speech and Swallowing in Degenerative Diseases. Austin, Texas: Pro-ed; 2004.
144. Roche V. Percutaneous endoscopic gastrostomy. Clinical care of PEG tubes in older adults. Geriatrics. 2003;58(11):22–6.
145. Loeb M, McGeer A, McArthur M, ve ark. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med. 1999;159(17):2058–64. 146. Opilla M. Aspiration risk and enteral feeding: a clinical approach. Pract Gastroenterol. 2003;1(27):89–96.
147. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003;124(1):328–36.
148. Ciocon JO, Silverstone FA, Graver LM, ve ark. Tube feedings in elderly patients: indications, benefits, and complications. Arch Intern Med. 1988;148(2):429–33.
149. Baijens LWJ, Speyer R, Passos VL, ve ark. The effect of surface electrical stimulation on swallowing in dysphagic parkinson patients. Dysphagia. 2012;27(4):528–37.
150. Heijnen BJ, Speyer R, Baijens LW, ve ark. Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson’s disease and oropharyngeal dysphagia: effects on quality of life. Dysphagia. 2012;27(3):336-45.
151. Lengerer S, Kipping J, Rommel N, ve ark. Deep brain stimulation does not impair deglutition in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:847–53.
152. Sunstedt S, Olofsson K, van Doorn J, ve ark. Swallowing function in Parkinson’s patients following zona incerta deep brain stimulation. Acta Neurol Scand. 2012;12:350–6.
153. Kulneff L, Sundstedt S, Olofsson K, ve ark. Deep brain stimulation-effects on swallowing function in Parkinson’s disease. Acta Neurol Scand. 2012;1:1–8.
154. Silbergleit AK, Lewitt P, Junn F, ve ark. Comparison of dysphagia before and after deep brain stimulation in Parkinson’s disease. Mov Disord. 2012;27:1763–8.
155. Kitashima A, Umemoto G, Tsuboi Y, ve ark. Effects of subthalamic nucleus deep brain stimulation on the swallowing function of patients with Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:480-2.
156. Ciucci MR, Brakmeier-Kraemer JM, Shermann SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease. Mov Disord. 2008;23(5):676–83.
157. Xie T, Vigil J, MacCracken E, ve ark. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 2015;84(4):415–20.
158. Xie T, Bloom L, Padmanaban M, ve ark. Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. J Neurol Neurosurg Psychiatry. 2018;89:989–94.
159. Derrey S, Chastan N, Maltete D, ve ark. Impact of deep brain stimulation on pharyngo-esophageal motility: a randomized cross-over study. Neurogastroenterol Motil. 2015;27:1214–22.
160. Shin J, Yang E, Cho K, ve ark. Clinical application of repetitive transcranial magnetic stimulation in stroke rehabilitation. Neural Regen Res. 2012;7(8):627–34.
161. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg. 2008;16(3):205–10.
162. Khedr EM, Mohamed KO, Soliman RK, ve ark. The effect of high-frequency repetitive transcranial magnetic stimulation on advancing Parkinson’s disease with dysphagia: double blind randomized clinical trial. Neurorehabil Neural Repair. 2019;33(6):442-52.

Toplam 355 adet kaynakça vardır.

Ayrıntılar

Birincil Dil	Türkçe
Konular	İç Hastalıkları
Bölüm	Derleme
Yazarlar	Merve Sapmaz Atalar 0000-0003-2556-1026 Gençer Genç 0000-0002-8094-3062
Yayımlanma Tarihi	24 Ağustos 2022
Gönderilme Tarihi	31 Temmuz 2021
Yayımlandığı Sayı	Yıl 2022 Cilt: 9 Sayı: 2

Kaynak Göster

APA	Sapmaz Atalar, M., & Genç, G. (2022). Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 9(2), 189-203. https://doi.org/10.47572/muskutd.974435
AMA	Sapmaz Atalar M, Genç G. Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım. MMJ. Ağustos 2022;9(2):189-203. doi:10.47572/muskutd.974435
Chicago	Sapmaz Atalar, Merve, ve Gençer Genç. “Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım”. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 9, sy. 2 (Ağustos 2022): 189-203. https://doi.org/10.47572/muskutd.974435.
EndNote	Sapmaz Atalar M, Genç G (01 Ağustos 2022) Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 9 2 189–203.
IEEE	M. Sapmaz Atalar ve G. Genç, “Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım”, MMJ, c. 9, sy. 2, ss. 189–203, 2022, doi: 10.47572/muskutd.974435.
ISNAD	Sapmaz Atalar, Merve - Genç, Gençer. “Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım”. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 9/2 (Ağustos 2022), 189-203. https://doi.org/10.47572/muskutd.974435.
JAMA	Sapmaz Atalar M, Genç G. Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım. MMJ. 2022;9:189–203.
MLA	Sapmaz Atalar, Merve ve Gençer Genç. “Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım”. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, c. 9, sy. 2, 2022, ss. 189-03, doi:10.47572/muskutd.974435.
Vancouver	Sapmaz Atalar M, Genç G. Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım. MMJ. 2022;9(2):189-203.

Cited By

Drooling may be Associated with Dysphagia Symptoms in Multiple Sclerosis

Dysphagia

https://doi.org/10.1007/s00455-024-10666-6

Dysphagia in Indivuduals with Huntington's Disease: A Narrative Review

European Journal of Therapeutics

https://doi.org/10.58600/eurjther1914

Reliability and validity study of a Turkish version of the Communicative Effectiveness Survey‐Revised (CES‐R)

International Journal of Language & Communication Disorders

https://doi.org/10.1111/1460-6984.12932

Kapak Resmi İndir

Makale Dosyaları

Tam Metin